Posted by Michael Wonder on 14 Dec 2022
HIRA sets up system to manage 'super-expensive' drugs
14 December 2022 - The Health Insurance Review and Assessment Service (HIRA) said it would operate a system to manage “super-expensive” drugs, such as Kymriah and Zolgensma, including their course of medication.
The state run agency said Wednesday that it would run the system to “manage expensive drugs” to enhance the efficiency of evaluating and analysing patients' responses to these expensive drugs and convenience in data submission.
